載入...
The Risk Factors for the Wearing-Off Phenomenon in Parkinson's Disease
Introduction: First-line treatment of Parkinson's disease (PD) includes a dopamine analog, levodopa, administered in combination with carbidopa to increase efficacy. Wearing-off (WO) phenomenon is a frequent complication which is defined as a reoccurrence of motor and non-motor symptoms during...
Na minha lista:
| 發表在: | Cureus |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Cureus
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7599057/ https://ncbi.nlm.nih.gov/pubmed/33145134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.10729 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|